Kangmei Pharmaceutical Co.,Ltd. Posted 885 Million Yuan Net Loss in First Three Quarters of 2022

Kangmei Pharmaceutical Co.,Ltd. (康美药业股份有限公司) (600518.SH) reported a net loss of 885 million yuan in the first three quarters of 2022, narrowing 13.8% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, down 11.8% year-on-year.

At the end of the reporting period, it had 15.6 billion yuan in total assets and 6.5 billion yuan in total liabilities, with a liability-to-asset ratio of 41.7%.